Hints and tips:
Related Topics
...I remember exactly where I lost an enormous fish in DePuy Spring Creek, not far from here. It went downstream and never came back. That was more than 10 years ago....
...He was global president of Johnson & Johnson’s DePuy Synthes Spine franchise. Willkie Farr & Gallagher has hired Caleb Vesey as a private equity partner in its Los Angeles office....
...Before Alere, Mr Nawana spent more than 15 years at Johnson & Johnson, including time as president of its DePuy Synthes spine business....
...Lack of scale is not necessarily a disadvantage, Medacta’s 32 per cent operating margins are in line with large peers such as Zimmer Biomet and DePuy Synthes....
...The verdict includes $1bn in punitive damages against J&J and DePuy, a subsidiary, as well as $30m in actual damages for the plaintiffs, according to Mark Lanier, the lead attorney for the plaintiffs....
...Johnson & Johnson, whose Depuy division has long been among the potential bidders for S&N, said on an earnings call that it intends to make acquisitions in 2016....
...S&N added 1.8 per cent to £11.65 on talk of interest from Johnson & Johnson, whose DePuy orthopaedic subsidiary was pushed to number three in the market for knee implants by Zimmer’s purchase of Biomet....
...Another theory doing the rounds was that J&J could carve up S&N and spin out its DePuy orthopaedics division into the UK listing as a way to minimise tax....
...Orthopaedics maker Smith & Nephew edged 0.3 per cent lower at 871.5p after weaker than expected earnings from Johnson & Johnson’s competing division, Global DePuy....
...Andrew Ekdahl, worldwide president of DePuy Synthes Joint Reconstruction, said: “The US settlement programme provides compensation for eligible patients without the delay and uncertainty of protracted litigation...
...The company took unspecified litigation charges, against a backdrop of continuing legal actions including compensation demands from users of its DePuy ASR artificial hip....
...The company is also facing an onslaught of lawsuits related to faulty hip implants produced by its DePuy unit....
...Ricks’s tales of the life and influence of General William DePuy offer a thread that ties together much of his story: after heroic service as a junior officer in the second world war, DePuy is an example...
...DePuy, the division of J&J that Synthes would potentially join, made revenues of $5.6bn but supposedly lower profitability....
...DePuy, a division of Johnson & Johnson, the largest US healthcare group, on Wednesday crystallised the value of that initiative by agreeing one of the biggest ever takeovers in the medical devices sector...
...Results from DePuy, Johnson & Johnson’s orthopaedics division, and Stryker, both highlighted slowing demand for replacement knees, an important product segment for S&N....
...The UK’s Medicines and Healthcare Products Regulatory Agency, for example, was the first to identify problems with DePuy’s ASR artificial metal hips, triggering recalls in 2009 and 2010....
...J&J booked $271m of charges related to its DePuy ASR, a hip replacement which had to be recalled....
...This was mainly due to a $922m charge related to the ASR hip recall from its DePuy subsidiary....
...Last year J&J took after-tax charges of $922m due to lawsuits related to its DePuy ASR replacement hip, which was recalled, and other product liabilities and litigation....
...Mr Dougall, a former vice-president of DePuy International, a Leeds-based subsidiary of Johnson & Johnson of the US, was one of the administrators of a conspiracy to pay £4.5m of bribes to Greek healthcare...
...J&J was hit by $271m of charges related to its DePuy ASR, a hip replacement which had to be recalled....
...The company took after-tax charges of $922m during the year to cover the impact of litigation around its DePuy ASR replacement hip, which was recalled, and other product liabilities and litigation....
...Once combined with J&J’s DePuy business it would have a 35 per cent global market share in hips and knees. S&N is also big in arthroscopy — around a third of the global market according to Merrill....
...Among the fallers, Smith & Nephew slid 2.3 per cent to 587p after Johnson & Johnson gave cautious guidance for its DePuy division, a direct competitor for S&N....
International Edition